OTCMKTS:WLYYF

WELL Health Technologies Competitors

$6.00
-0.04 (-0.66 %)
(As of 04/15/2021 12:00 AM ET)
Add
Compare
Today's Range
$5.87
Now: $6.00
$6.15
50-Day Range
$5.67
MA: $6.29
$7.45
52-Week Range
$1.19
Now: $6.00
$8.00
Volume22,755 shs
Average Volume45,253 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

WELL Health Technologies (OTCMKTS:WLYYF) Vs. BNVIF, CNONF, DOCRF, EVAHF, EWLL, and FORA

Should you be buying WLYYF stock or one of its competitors? Companies in the industry of "health information services" are considered alternatives and competitors to WELL Health Technologies, including Binovi Technologies (BNVIF), CannaOne Technologies (CNONF), CloudMD Software & Services (DOCRF), EGF Theramed Health (EVAHF), eWellness Healthcare (EWLL), and Forian (FORA).

WELL Health Technologies (OTCMKTS:WLYYF) and Binovi Technologies (OTCMKTS:BNVIF) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, analyst recommendations, dividends, valuation, risk, institutional ownership and earnings.

Analyst Recommendations

This is a summary of current recommendations and price targets for WELL Health Technologies and Binovi Technologies, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
WELL Health Technologies00403.00
Binovi Technologies0000N/A

WELL Health Technologies currently has a consensus price target of $10.8333, indicating a potential upside of 80.56%. Given WELL Health Technologies' higher probable upside, equities research analysts plainly believe WELL Health Technologies is more favorable than Binovi Technologies.

Profitability

This table compares WELL Health Technologies and Binovi Technologies' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
WELL Health TechnologiesN/AN/AN/A
Binovi TechnologiesN/AN/AN/A

Earnings and Valuation

This table compares WELL Health Technologies and Binovi Technologies' gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
WELL Health TechnologiesN/AN/AN/AN/AN/A
Binovi TechnologiesN/AN/AN/AN/AN/A

Summary

WELL Health Technologies beats Binovi Technologies on 2 of the 2 factors compared between the two stocks.

WELL Health Technologies (OTCMKTS:WLYYF) and CannaOne Technologies (OTCMKTS:CNONF) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, analyst recommendations, dividends, valuation, risk, institutional ownership and earnings.

Analyst Recommendations

This is a summary of current recommendations and price targets for WELL Health Technologies and CannaOne Technologies, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
WELL Health Technologies00403.00
CannaOne Technologies0000N/A

WELL Health Technologies currently has a consensus price target of $10.8333, indicating a potential upside of 80.56%. Given WELL Health Technologies' higher probable upside, equities research analysts plainly believe WELL Health Technologies is more favorable than CannaOne Technologies.

Profitability

This table compares WELL Health Technologies and CannaOne Technologies' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
WELL Health TechnologiesN/AN/AN/A
CannaOne TechnologiesN/AN/AN/A

Earnings and Valuation

This table compares WELL Health Technologies and CannaOne Technologies' gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
WELL Health TechnologiesN/AN/AN/AN/AN/A
CannaOne TechnologiesN/AN/AN/AN/AN/A

Summary

WELL Health Technologies beats CannaOne Technologies on 2 of the 2 factors compared between the two stocks.

WELL Health Technologies (OTCMKTS:WLYYF) and CloudMD Software & Services (OTCMKTS:DOCRF) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, analyst recommendations, dividends, valuation, risk, institutional ownership and earnings.

Analyst Recommendations

This is a summary of current recommendations and price targets for WELL Health Technologies and CloudMD Software & Services, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
WELL Health Technologies00403.00
CloudMD Software & Services00203.00

WELL Health Technologies currently has a consensus price target of $10.8333, indicating a potential upside of 80.56%. CloudMD Software & Services has a consensus price target of $3.3750, indicating a potential upside of 103.31%. Given CloudMD Software & Services' higher probable upside, analysts plainly believe CloudMD Software & Services is more favorable than WELL Health Technologies.

Profitability

This table compares WELL Health Technologies and CloudMD Software & Services' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
WELL Health TechnologiesN/AN/AN/A
CloudMD Software & ServicesN/AN/AN/A

Earnings and Valuation

This table compares WELL Health Technologies and CloudMD Software & Services' gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
WELL Health TechnologiesN/AN/AN/AN/AN/A
CloudMD Software & ServicesN/AN/AN/AN/AN/A

WELL Health Technologies (OTCMKTS:WLYYF) and EGF Theramed Health (OTCMKTS:EVAHF) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, analyst recommendations, dividends, valuation, risk, institutional ownership and earnings.

Analyst Recommendations

This is a summary of current recommendations and price targets for WELL Health Technologies and EGF Theramed Health, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
WELL Health Technologies00403.00
EGF Theramed Health0000N/A

WELL Health Technologies currently has a consensus price target of $10.8333, indicating a potential upside of 80.56%. Given WELL Health Technologies' higher probable upside, equities research analysts plainly believe WELL Health Technologies is more favorable than EGF Theramed Health.

Profitability

This table compares WELL Health Technologies and EGF Theramed Health's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
WELL Health TechnologiesN/AN/AN/A
EGF Theramed HealthN/AN/AN/A

Earnings and Valuation

This table compares WELL Health Technologies and EGF Theramed Health's gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
WELL Health TechnologiesN/AN/AN/AN/AN/A
EGF Theramed HealthN/AN/AN/AN/AN/A

Summary

WELL Health Technologies beats EGF Theramed Health on 2 of the 2 factors compared between the two stocks.

WELL Health Technologies (OTCMKTS:WLYYF) and eWellness Healthcare (OTCMKTS:EWLL) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, analyst recommendations, risk, dividends, institutional ownership, earnings and profitability.

Valuation and Earnings

This table compares WELL Health Technologies and eWellness Healthcare's gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
WELL Health TechnologiesN/AN/AN/AN/AN/A
eWellness HealthcareN/AN/AN/AN/AN/A

Profitability

This table compares WELL Health Technologies and eWellness Healthcare's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
WELL Health TechnologiesN/AN/AN/A
eWellness HealthcareN/AN/AN/A

Analyst Ratings

This is a summary of current ratings and price targets for WELL Health Technologies and eWellness Healthcare, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
WELL Health Technologies00403.00
eWellness Healthcare0000N/A

WELL Health Technologies currently has a consensus price target of $10.8333, indicating a potential upside of 80.56%. Given WELL Health Technologies' higher probable upside, analysts clearly believe WELL Health Technologies is more favorable than eWellness Healthcare.

Summary

WELL Health Technologies beats eWellness Healthcare on 2 of the 2 factors compared between the two stocks.

Forian (NASDAQ:FORA) and WELL Health Technologies (OTCMKTS:WLYYF) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, valuation, profitability, earnings, analyst recommendations, institutional ownership and dividends.

Analyst Ratings

This is a breakdown of current recommendations for Forian and WELL Health Technologies, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Forian0000N/A
WELL Health Technologies00403.00

WELL Health Technologies has a consensus target price of $10.8333, indicating a potential upside of 80.56%. Given WELL Health Technologies' higher probable upside, analysts plainly believe WELL Health Technologies is more favorable than Forian.

Valuation and Earnings

This table compares Forian and WELL Health Technologies' revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ForianN/AN/AN/AN/AN/A
WELL Health TechnologiesN/AN/AN/AN/AN/A

Profitability

This table compares Forian and WELL Health Technologies' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
ForianN/AN/AN/A
WELL Health TechnologiesN/AN/AN/A

Summary

WELL Health Technologies beats Forian on 2 of the 2 factors compared between the two stocks.


WELL Health Technologies Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
Binovi Technologies logo
BNVIF
Binovi Technologies
0.0$0.06-2.2%$0.00N/A0.00Decrease in Short Interest
Gap Down
CannaOne Technologies logo
CNONF
CannaOne Technologies
0.6$0.98-9.2%$0.00N/A0.00Decrease in Short Interest
CloudMD Software & Services logo
DOCRF
CloudMD Software & Services
1.7$1.66-0.6%$0.00N/A0.00Decrease in Short Interest
EGF Theramed Health logo
EVAHF
EGF Theramed Health
0.0$0.11-7.5%$0.00N/A0.00Decrease in Short Interest
News Coverage
Gap Down
EWLL
eWellness Healthcare
0.6$0.00-0.0%$0.00N/A0.00
FORA
Forian
0.3$11.55-4.8%$0.00N/A0.00Gap Up
M3 logo
MTHRF
M3
1.0$76.00-0.3%$0.00N/A0.00
NEWUF
Newtopia
1.7$0.41-9.8%$0.00N/A0.00Gap Up
PANHF
Ping An Healthcare and Technology
1.0$12.20-2.5%$0.00N/A0.00Gap Up
Pro Medicus logo
PMCUF
Pro Medicus
0.5$35.65-1.8%$0.00N/A0.00Decrease in Short Interest
CBIIF
Skylight Health Group
0.0$0.95-1.0%$0.00N/A0.00News Coverage
UCBB
US-China Biomedical Technology
0.3$0.13-0.0%$0.00N/A0.00
This page was last updated on 4/16/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.